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Background - Ultrasound imaging is able to quantify carotid arterial wall structure for 3	
assessment of cerebral and cardiovascular disease risks. We describe a protocol and quality 4	
assurance process to enable carotid imaging at large scale that has been developed for the UK 5	
Biobank Imaging Enhancement Study of 100,000 individuals. 6	
Design - An imaging protocol was developed to allow measurement of carotid intima-media 7	
thickness (CIMT) from the far wall of both common carotid arteries. Six quality assurance 8	
criteria were defined and a web-based interface (Intelligent Ultrasound) was developed to 9	
facilitate rapid assessment of images against each criterion.  10	
Results and Conclusions – Excellent inter- and intra-observer agreements were obtained for 11	
image quality evaluations on a test dataset from 100 individuals. The image quality criteria 12	
then were applied in the UK Biobank Imaging Enhancement Study. Data from 2560 13	
participants was evaluated. Feedback of results to the imaging team led to improvement in 14	
quality assurance (QA), with QA failures falling from 16.2% in the first two-month period 15	
examined to 6.4% in the last. 80% had all CIMT images graded as of acceptable quality, with 16	
at least one image acceptable for 98% of participants.  CIMT measures showed expected 17	
associations with increasing age and gender.  18	
Carotid imaging can be performed consistently, with semi-automated quality assurance of all 19	
scans, in a limited time frame within a large scale multimodality imaging assessment. 20	
Routine feedback of quality control metrics to operators can improve the quality of the data 21	
collection.  22	
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INTRODUCTION 1	
UK Biobank is a prospective study of 500,000 people aged between 40 and 69 years at 2	
recruitment between 2006 and 2010.1 An initial feasibility assessment (pilot phase) was 3	
initiated in 2014, to evaluate the feasibility of conducting a multi-modal imaging study in 4	
100,000 participants over 6 years, including MRI scans of the brain, heart and body, a dual-5	
energy X-ray absorptiometry (DEXA) scan and a carotid ultrasound.2 The large scale and the 6	
richness of the phenotyping in UK Biobank allows researchers to examine aspects of 7	
cardiovascular epidemiology that previously would not have been possible. 8	
 9	
Imaging of the carotid vessels can provide information on the thickness of the carotid vessels, 10	
expressed as the carotid intima media thickness (CIMT), and the presence of carotid plaque.  11	
Information concerning both has been associated with incident cardiovascular events.3–5 Use 12	
of ultrasound to image the carotids has the advantage of being relatively low-cost, fast, free 13	
of ionizing radiation, and requiring relatively little training to use,6 leading to its successful 14	
use in a number of large population-based cohort studies.4,5,7,8 Good reproducibility is seen 15	
even among relatively inexperienced operators under routine clinical conditions.6 However, 16	
imaging on the scale of UK Biobank is unprecedented and requires adaptation of usual 17	
approaches that allow both efficient data acquisition and exceptional attention to quality 18	
assurance, to avoid bias and minimise measurement variation over time. Previous 19	
publications have described the UK Biobank in general,1 and the imaging substudies 20	
involving cardiac MRI,2,9 liver MRI,10 and brain MRI.11 In this article, we describe the 21	
carotid ultrasound scanning protocol used within the UK Biobank Imaging Enhancement 22	
study and the development of a quality assurance process. We also report an evaluation of 23	






A protocol was developed based on reported guidelines for carotid image acquisition12,13 that 5	
took account of the practical aspects of space for equipment, time available and the limited 6	
experience of the technicians. In addition, the requirement for potential future analysis of raw 7	
ultrasound data was considered in acquisition of images. The protocol was devised to operate 8	
alongside the other planned assessments for the Imaging Enhancement of UK Biobank 9	
(cardiovascular, brain and abdominal magnetic resonance imaging, DEXA, as well as a 10	
repeat of the study’s baseline measures, which incorporate a comprehensive computer-based 11	
questionnaire with interview, physical measures, and blood and urine sampling). 	12	
	13	
The flowchart for the protocol developed is shown in Figure 1. An abbreviated version of the 14	
UK Biobank Standard Operating Protocol is available from 15	
http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=511.  In the pilot phase, imaging was 16	
performed solely at the UK Biobank imaging facility at Cheadle, Stockport, UK. In brief, a 17	
CardioHealth Station (Panasonic Healthcare Corporation of North America, Newark, NJ, 18	
USA) was used, with a 9MHz linear array transducer. The carotid study was performed in a 19	
darkened room and participants lay supine supported by a triangular pillow. Initially, a 2D 20	
sweep of both carotids was performed along the short-axis (transverse plane) from low in the 21	
neck up to the jaw, at least to the level of the carotid bifurcation, with the right carotid 22	
scanned first. The conventionally configured CardioHealth Station user interface software 23	
allows these sweeps to be performed but not stored. To meet the needs of the UK Biobank, 24	
this interface was modified prior to commencement of the study to allow cine image loop 25	
	 7	
storage. The sweep was repeated in the long-axis (longitudinal plane) and stored. These 1	
longitudinal images were also used to identify the bifurcation for measurement of CIMT. 2	
This was performed at two angles for each carotid, giving a total of four CIMT 3	
measurements, which when measured from the vertical axis were 150o and 120o on the right 4	
carotid, and 210o and 240o on the left carotid. Automated position location identification 5	
provided a real-time readout of the transducer angle to the technician. The CIMT was 6	
measured at time of acquisition using the semi-automated CardioHealth Station hardware and 7	
software, with ‘Auto ROI’ and ‘Auto Freeze’ enabled.  The CHS software places a marker on 8	
the screen to guide the user in alignment of the flow divider and a 10mm region-of-interest 9	
box to facilitate CIMT measurement. The far-wall of the common carotid was then 10	
automatically tracked by the region-of-interest box.  When three consecutive cardiac cycles 11	
met internal quality thresholds, the image auto-froze in end-diastole, giving the mean, 12	
maximum and minimum of the CIMT tracking. Manual override of the automatically derived 13	
CIMT boundaries was performed in cases where the detected boundaries did not align with 14	
the underlying B-mode image, and manual override of the auto-freeze feature was performed 15	
if auto-freeze was not invoked after prolonged period of scanning. The technician also had 16	
the facility to adjust the image to ensure the CIMT measurement was not taken at sites of 17	
focal plaque, defined based on the Mannheim Consensus as: “a focal structure that 18	
encroaches into the arterial lumen of at least 0.5mm or 50% of the surrounding IMT value or 19	





Development of Quality Criteria - To develop quality assurance (QA) processes for carotid 1	
imaging, we reviewed available literature on protocols used in previous studies and also 2	
criteria described for carotid image quality.5,12–15 No specific guidelines for quality assurance 3	
for a study of this size (i.e. for 100,000 participants) were identified in literature review. 4	
Thus, we defined six QA criteria based on how a technician is trained to handle the probe and 5	
identify the region of interest when acquiring a carotid image, as described below: 6	
1. Horizontal. The whole carotid (not just at the location of the box) lies approximately 7	
horizontal on the image, with >75% of the long axis of the carotid < 15 degrees above 8	
or below the horizontal. 9	
2. Oblique (also referred to as arterial misalignment). The section obtained should be 10	
along the long-axis of the carotid, with >80% of the visualised common carotid 11	
showing parallel near and far carotid walls. 12	
3. Box location. The distal edge of the box for automated CIMT measurement should be 13	
positioned 1cm proximal to the flow divider of the carotid bulb, and there should be 14	
no focal plaque within the box. 15	
4. White-black-white. The CIMT should have distinct borders that define a clear 16	
“white-black-white” pattern on the monitor. 17	
5. CIMT tracking. The automated CIMT measurement was recorded at the correct time 18	
in the cardiac cycle (end-diastole) and > 50% of the CIMT within the measurement 19	
box has been tracked. All areas of CIMT tracked should accurately align with the B-20	
mode image.  21	
6. Angle. The acquisition angle of the image should have been recorded within 30 22	
degrees of the selected angle category (i.e., for images selected to represent 120 23	
degrees, the acceptable range is 90-150 degrees).  24	
	 9	
Based on these six quality criteria, we developed a single Pass/Fail QA flag for images. For 1	
an image to pass the overall QA, an image needed to pass all of the individual criteria of box 2	
position and CIMT tracking, but could fail one of horizontal, oblique or white-black-white 3	
criteria. For each participant, a carotid study consisted of four images showing the CIMT 4	
measurement acquired at predefined angles of acquisition (i.e., right 150o, right 120o, left 5	
210o, and left 240o). A separate QA flag was generated for each angle of acqusition. 	6	
Assessment of Quality Criteria - To evaluate our approach, we used a test dataset of 100 7	
carotid studies to estimate both inter and intra-observer reproducibility of the quality criteria, 8	
after which we evaluated the process as a whole in the Pilot Phase (2567 subjects, of whom 9	
2560 had a QA assessment at each angle of acquisition). To ensure consistency in application 10	
of these criteria, we developed a web-based interface to allow the rapid semi-automated 11	
review of images. The images were loaded into a simple custom designed grading tool 12	
(Intelligent Ultrasound Ltd, Abingdon, United Kingdom), and each image was assessed twice 13	
(on separate occasions) by three clinicians experienced in grading carotid ultrasound images, 14	
henceford called graders. When assessing inter- and intra-observer reliability or agreement, 15	
measures that adjust the raw percentage agreement by that expected due to chance are used, 16	
such as Cohen’s kappa. However, Cohen’s kappa and its direct extensions tend to show 17	
paradoxical behaviour at the extremes of prevalence (for example, as in our case, if a large 18	
majority of images passed QA assessment), with very high agreement between observers 19	
sometimes even leading to negative kappas.16,17 We therefore used Gwet’s first order 20	
agreement coefficient, referred to as the AC1 statistic, to assess reliability. This, like Cohen’s 21	
kappa, is 0 in cases of no agreement and 1 in cases of perfect agreement, but incorporates 22	
observer uncertainty into the model and tends to be less affected by prevalence.17,18  23	
Application of Quality Assurance and Quality Audit in Pilot Phase - Participant age was 24	
provided and analysed according to decade of birth, with age groups of ≤50, 51-60, 61-70, 25	
	 10	
and ≥71 years at the time of carotid ultrasound. Once the QA criteria were finalised, all 1	
studies acquired were reviewed for quality assurance (QA) purposes by a trained UK 2	
Biobank senior radiographer and information fed back to the sonographers on a weekly basis. 3	
Images from each of the four acquired angles were graded as Pass/Fail, according to the 4	
developed criteria and based on an overall assessment of each image. A random selection of 5	
approximately 10% of these images, as well as any borderline images, were reviewed by 6	
expert staff in the Oxford Cardiovascular Clinical Research Facility. Results from the 7	
external review were fed back to the imaging centre on a monthly basis to complete the audit 8	
cycle, with teleconferences as required to discuss any specific issues. 9	
Statistical Analysis - At the end of the pilot phase, we used the available data on CIMT, 10	
quality assurance and the age and sex of participants to investigate the overall validity of the 11	
acquired carotid measurements. Specifically, we studied associations between CIMT and age 12	
and sex, reasoning that measured CIMT should be higher in older age groups and in male 13	
participants. We used multivariate linear regression, with predictor variables of age (as an 14	
ordered categorical variable based on decade) and sex. We then assessed the impact of the 15	
quality assurance process on carotid measures by studying how the model fit varied if images 16	
that failed QA were excluded.  We did this based on exclusion of all studies in which one 17	




Assessment of Quality Criteria - 588 images from 100 participants acquired during the pilot 22	
phase of the UK Biobank Imaging Enhancement were graded in the semi-automated tool 23	
(Figure 2A) by three graders on two separate occasions. More than one image from each 24	
angle of acquisition was eligible for assessment during this phase of the QA process. Overall, 25	
there was a very good agreement between evaluations performed by different graders 26	
	 11	
(Supplementary Figure 1, Supplementary Table 1). All criteria showed excellent intra-1	
observer reliability (minimum Gwet AC1 88%), with good inter-observer reliability 2	
(minimum Gwet AC1 78%). Examples of images passing and failing QA are shown in Figure 3	
2B-G.	4	
Application of Quality Assurance and Quality Audit -   Images from the first 2567 5	
participants after implementation of the QA protocol were evaluated. Pass/Fail QA flags for 6	
all four angles of acquisition were available for 2560 participants, and, of these, 2519 (98%) 7	
had at least one image passing QA.  523 (20%) studies had at least one image failing QA but 8	
the proportion of images failing QA decreased over time, with an average across views of 9	
16.2% failing QA in the first two month period compared to 6.4% failing in the last two 10	
month period analysed (Supplementary Figure 2). 11	
	Evaluation of validity of carotid datasets 12	
Data for evaluation of associations were available for 2558 of the 2567 participants. Based on 13	
the entire dataset, mean CIMT was higher in older, compared with younger, age groups and 14	
was higher in men than in women (Table 1, Supplementary Figure 3). A linear regression 15	
model (Table 2) showed a 61µm (95% CI: 55-67µm) increase in CIMT per decade, and a 16	
48µm (95% CI: 39-57µm) increase in male compared to female participants compared to the 17	
average CIMT of 553µm (95% confidence interval (95% CI): 542-564µm) in 45-50 year old 18	
females in the model (adjusted R2 0.191, p<2x10-16). Studies with one image that failed QA 19	
tended to have on average a 46µm greater CIMT (Supplementary Figure 3) and a linear 20	
regression model with a QA flag (indicating any image failing QA) had slightly higher 21	
adjusted R2 than the model without the QA flag (Table 2). However, the confidence interval 22	
for reference CIMT in younger females, as well as those of older age and male sex, was very 23	
	 12	
similar under both models, suggesting that the impact of including ‘failed’ images on the 1	
overall assessment is small. 2	
 3	
DISCUSSION 4	
We describe a protocol for carotid image acquisition and semi-automated measurement of 5	
carotid IMT within a limited timeframe for application within a large cohort study. 6	
Furthermore, we describe development of quality assurance criteria to allow evaluation of 7	
quality of images and audit control. Application of these procedures reduced the number of 8	
quality fails within scans and helped to ensure that 98% of participants had at least one CIMT 9	
measure. Analysis of the dataset confirms that the CIMT measures within the UK Biobank 10	
Imaging Enhancement pilot phase associate with age and sex in the expected way, implying 11	
face validity of the measures. 12	
 13	
A key feature of the UK Biobank imaging protocol is that it needs to be performed within a 14	
limited time frame in participants who also undergo abdominal, cardiac and brain magnetic 15	
resonance imaging, dual energy X-ray absorptiometry (DEXA), blood sampling and an 16	
extensive questionnaire. During the study visit, only 10 minutes is available for carotid 17	
imaging, including time for patient registration. In addition to this time constraint, we expect 18	
that data acquisition will be performed by multiple technicians at three separate imaging 19	
assessment centres over the course of the Imaging Enhancement Study (which will take 6-7 20	
years). Our protocol was therefore developed to achieve a relatively detailed image 21	
acquisition in a highly reproducible manner. A recent meta-analysis highlights the variability 22	
in CIMT measurements across studies.20 The use of semi-automated measurement techniques 23	
is recommended in international consensus statements to reduce inter-observer variability,12,13 24	
and we therefore chose an ultrasound system that implements these. In addition, the 25	
	 13	
CardioHealth Station system we used has been shown to have excellent reproducibility even 1	
in less-experienced users.6,21,22  2	
 3	
A potential limitation of the protocol at this time is the lack of quantification of the plaque 4	
that may be present in the images. Focal plaque has been shown to provide additional 5	
discrimination above that provided by CIMT measurement alone.23,24 However, the additional 6	
discrimination is modest (area under the receiver operating curve 0.64 for plaque vs 0.61 for 7	
CIMT as a predictor of myocardial infarction over an average of eight years in a large meta-8	
analysis).24 As the assessment of plaque is much more subjective, it is both operator 9	
dependent and time consuming. Therefore it was not considered practical to provide 10	
evaluation of plaque at the time of image acquisition. However, the image acquisition 11	
protocol provides both a short axis 2D sweep along the length of the carotid as well as 12	
longitudinal views to above the bifurcation. Retrospective evaluation of stored image datasets 13	
will therefore be possible to assess plaque characteristics and other novel carotid parameters 14	
– these images will be available to external researchers. In addition, these stored raw image 15	
datasets have the potential to be used for future novel metric evaluations including, for 16	
example, assessment of geometric variation or measurements of intima media thickness in 17	
other locations within the vessel. By linking these measures to the available imaging 18	
modalities or later clinical outcomes, potentially new carotid biomarkers of cerebral or 19	
cardiovascular health could be identified. 20	
 21	
The within and between rater reliability of our QA criteria suggest they can be applied with 22	
little inter- or intra-observer variability. A number of these criteria, such as the “White-Black-23	
White” criterion, are integral to CIMT measurement, while others, such as the exclusion of 24	
	 14	
focal plaque from the measurement box, were chosen to increase reproducibility. The 1	
“Angle” criterion has relatively relaxed requirements for the angle of acquisition, as we 2	
decided that the exact angle of acquisition was not as important as repeated measurements of 3	
the two carotids in this single time point study, and therefore should not lead to failure of the 4	
entire carotid study. With the development of a standardised interface for grading the quality 5	
of the images acquired and a larger number of studies acquired it may be possible to develop 6	
image analysis techniques that would automate the QA process further.  7	
 8	
The impact of inclusion or exclusion of QA criteria on the model fit was very small and 9	
therefore data released by UK Biobank includes all CIMT measures irrespective of the QA 10	
flag. There was a higher rate of QA fails with older age, and the provision of QA flag may 11	
therefore be of scientific interest. There is a distinct possibility that future analyses will reveal 12	
that images that fail QA have predictive value in themselves. For example, it is possible that 13	
highly tortuous carotid arteries would be more likely to fail QA, and that the tortuosity is 14	
predictive of future cardiovascular events. The QA flag for each image is therefore provided 15	
along with the CIMT measure on the UK Biobank data showcase (available at 16	
biobank.ctsu.ox.ac.uk/showcase).  17	
 18	
A major advantage of the QA process is that real-time feedback is possible during training. 19	
The number of images failing QA during the course of the pilot phase more than halved 20	
following such feedback based on QA measures, with a rapid fall on implementation of the 21	
QA audit process and maintenance of lower levels thereafter. Interestingly, both left sided 22	
angles of acquisition had a higher failure rate initially, and appeared to have a more rapid 23	
improvement compared to right sided angles of acquisition. As we did not record handedness 24	
	 15	
of operators, we were unable to investigate this further. The audit process involved feedback 1	
to the technicians of both number of image fails and reasons for image quality failures. 2	
Furthermore, as each image could be identified by time and operator, the advice could be 3	
personalised for individual technicians to improve their carotid imaging technique. Several 4	
operators performed carotid imaging during the pilot phase and new operators started during 5	
that period. The QA criteria were introduced as part of the training for new technicians and 6	
each was required to show competency against the QA criteria in test cases before being 7	
allowed to scan participants. Therefore the maintenance of a low failure rate provides 8	
reassurance that the use of the QA criteria within training processes was also robust. 9	
In summary, carotid images and semi-automated CIMT measures are now available from the 10	
UK Biobank Imaging Enhancement Study. This is the first published description of the 11	
protocol used for acquisition of these images and the rationale for the design.  Furthermore, 12	
we provide a detailed evaluation of the quality assurance process, description of a semi-13	
automated online tool for rapid image evaluation and demonstrate that the data generated fits 14	
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≤ 50	 170	 588	(84)	 95	(56%)	 578	(76)	 600	(93)	 23	(14%)	
51-60	 787	 628	(107)	 451	(57%)	 607	(83)	 657	(126)	 119	(15%)	
61-70	 1180	 701	(123)	 596	(51%)	 675	(104)	 728	(134)	 238	(20%)	



































measurements	were	obtained:	right carotid at 150o, right carotid at 120o, left carotid at 210o, and 6	








































































































White	Black	White	 88.0%	 85.2%	(82.2%	-	88.1%)	 90.1%	(87.3%	-	92.9%)	
CIMT	accurate	 88.4%	 85.9%	(83.1%	-	88.8%)	 91.3%	(88.6%	-	93.9%)	
Box	Location	 92.9%	 92.3%	(90.3%	-	94.3%)	 94.7%	(93%	-	96.3%)	
Angle	 89.8%	 88.1%	(85.5%	-	90.7%)	 89.8%	(86.8%	-	92.7%)	
Oblique	 83.5%	 78.4%	(74.8%	-	82.1%)	 88.2%	(85%	-	91.5%)	
Horizontal	 95.6%	 95.3%	(93.8%	-	96.8%)	 97.4%	(96.2%	-	98.5%)	
	
The	inter-observer	and	intra-observer	Gwet	AC1	statistic	is	the	mean	value	
across	quality	criteria	assessment	runs	and	observers,	respectively.	
Abbreviation:	CI,	confidence	interval.	
